ArticleBritish journal of cancer2018

SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance.

Xiaodong Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.